This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference and Expo on Toxicology and Applied Pharmacology” (Toxicology 2023) Hybrid Event scheduled during June 12-13, 2023 | Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at [email protected] or call + 1 (702) 988 2320.
Human health risk assessment is the process of examining data to see if an environmental danger could harm people who are exposed to it. Many toxicological disciplines are incorporated into the risk-assessment process. It consists of four broad steps: hazard identification, dose-response assessment, exposure assessment, and risk characterization. It comprises both qualitative and quantitative components. Toxicogenomic data has the potential to be useful in all aspects of risk assessment. Toxicogenomic data, for example, could reveal the sorts of hazards a chemical pose (for example, whether it poses cancer or non-cancer risks) as well as the modes and processes of toxic action via which it functions in hazard identification. The method of action is also a factor to consider when determining the best technique to dose-response analysis. Toxicogenomic techniques may help with exposure assessment by indicating toxicant exposure in cells. Toxicogenomic data can also be utilised to better understand areas of ambiguity, such as human population variability, data extrapolation from one species to another, identification of vulnerable subpopulations, and quantitative data to improve risk assessments.
Risk management differs from risk assessment in that it focuses on the long-term consequences of an action. Risk assessment determines whether a risk exists and, if so, what the risk's range or magnitude is. The results of the risk assessment are combined with other factors, such as economic or legal issues, in the risk management process to make decisions on the need for and feasibility of undertaking various risk reduction activities. The results of risk assessments are also used by risk managers to communicate risks to interested parties and the general public.
Title : Countering bacterial antibiotic resistance
A C Matin, Stanford University School of Medicine, United States
Title : Functionalized PCL/PVP fibrous mats and their potential application as wound dressings
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Radio protective activity of serotonin- modulating anti consolidation protein
A.A.Mekhtiev, Academician Abdulla Garayev Institute of Physiology, Azerbaijan
Title : Vertebral primary bone lesions: When to intervene
Brandon Lucke Wold, University of Florida, United States
Title : Chemical carcinogens
Ana Faustino, University of Evora, Portugal
Title : Risk assessment of plastic additive (DEHP) on pearl spot (Etroplus suratensis)
Aniket Desai, CSIR- National Institute of Oceanography, India